Clinical Trials Browser

Phase 1/2 × Head and Neck Neoplasms × Sugars × Clear all

NCT01330446 2024-02-14

Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

Phase 1/2 Completed

26 enrolled 7 charts

Fatigue, Head and Neck Neoplasms